Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01200303 · ClinicalTrials.gov registry record · Phase 2
Evaluation of Computer-assisted, Non-cathartic CT Colonography
A Phase 2 study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- Phase 2
- Development phase
- 605
- Enrollment target
NCT01200303: Completed Phase 2 study, sponsored by Massachusetts General Hospital.
NCT01200303 is a Phase 2 study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 605 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (355% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01200303, a Phase 2 study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 605 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the performance of a non-cathartic, computer-assisted form of CT Colonography (Virtual Colonoscopy) for detection of pre-cancerous colon polyps in a group of asymptomatic screening patients.
Primary Outcome
this is a prospective test comparison of non-cathartic, CAD-assisted CT Colonography to segmentally unblinded optical colonoscopy (OC), latter serving with pathology specimens as reference standard for presence of polyps.
Interventions
- PROCEDURE non-cathartic CTC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 605 participants |
| Start Date | 2005-06 |
| Est. Completion | 2011-01 |
| Phase | Phase 2 |
What the finished NCT01200303 record still lists
NCT01200303 is an interventional study that assigns participants to a tested intervention. The registered 605 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (355% higher).
The record links to 0 conditions, and to 1 intervention - of which non-cathartic CTC is the first listed.
NCT01200303 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01200303 about?
NCT01200303 is a clinical study titled "Evaluation of Computer-assisted, Non-cathartic CT Colonography". The purpose of this study is to evaluate the performance of a non-cathartic, computer-assisted form of CT Colonography (Virtual Colonoscopy) for detection of pre-cancerous colon polyps in a group of asymptomatic screening patients.
What is the current status of trial NCT01200303?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 605 participants. The study started on 2005-06. Estimated completion is 2011-01.
What interventions are being tested in trial NCT01200303?
The interventions under investigation include: non-cathartic CTC (PROCEDURE).
Who is sponsoring clinical trial NCT01200303?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01200303's enrollment target sits among peer trials
605 53rd of 2000 higher than 1,948 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02342444 · 606 participants · Phase 4
Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD)
- NCT03849443 · 604 participants · Early Phase 1
Single Versus Multi-Dose Oral and Intravenous Tranexamic Acid Patients at High Risk for Blood Transfusion After Spine Surgery
- NCT05238922 · 604 participants · Phase 1
Study of INCB123667 in Subjects With Advanced Solid Tumors
- NCT06040541 · 604 participants · Phase 1
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia